Covered recipient · General Payments record
APARNA BABURAJ
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2024
$869.80
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $655.64 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $247.71 | 3 |
| Amgen Inc. | $130.14 | 1 |
| Lilly USA, LLC | $110.49 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $108.64 | 1 |
| DEXCOM, INC. | $41.66 | 2 |
| Esperion Therapeutics, Inc. | $17.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $130.14 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117498954 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.52 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086212093 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $109.14 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086168036 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $123.05 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086259500 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $108.64 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118059419 | CMS |
| Dexcom, Inc. | $24.75 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153282510 | CMS |
| Dexcom, Inc. | $16.91 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153282514 | CMS |
| Esperion Therapeutics, Inc. | $17.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129426870 | CMS |
| Lilly USA, LLC | $110.49 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136050247 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.